AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2015

Aug 14, 2015

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2015-08-13

Reporting Person: Equels Thomas K. (Director, CFO, Pres.,Sec., Vice Chairman)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-13	Common Stock	P	16504	$0.1798	Acquired	1321948	Direct
2015-08-13	Common Stock	P	12600	$0.18	Acquired	1334548	Direct
2015-08-14	Common Stock	P	50000	$0.1801	Acquired	1384548	Direct